- Home>
- Specialty Care>
- Oncology and Hematology>
- About>
- Disclosure Information
Disclosure Information
The editors of Journal Watch Oncology and Hematology have disclosed the following information in keeping with the conflict of interest policy of the MMS Professional Newsletters:
William J. Gradishar, MD, Editor-in-Chief
- Consultant / Advisory board
-
- Abraxis BioScience Inc.; AstraZeneca; Bristol-Myers Squibb; Genentech; Genomic Health; GlaxoSmithKline; Novartis; sanofi-aventis
- Speaker's bureau
-
- Abraxis BioScience Inc.; Amgen; AstraZeneca; Genentech; Novartis
- Grant / research support
-
- Breast Cancer Research Fund; various clinical trials
- Editorial boards
-
- Clinical Breast Cancer; Clinical Cancer Research; Journal of Clinical Oncology; Oncology
- Leadership positions in professional societies
-
- American Society of Clinical Oncology (Chair-Elect, Professional Development Committee)
Robert Dreicer, MD, MS, FACP, Associate Editor
- Consultant / Advisory board
-
- AstraZeneca; Celgene; EMD Sereno; Endo Pharmaceuticals; GTx Inc.; Millennium; Novartis; Ortho Biotech
- Speaker's bureau
-
- sanofi-aventis
- Grant / research support
-
- Millennium
- Editorial boards
-
- Journal of Supportive Oncology; Urology
David Green, MD, PhD, Associate Editor
- Consultant / Advisory board
-
- CVS-Caremark
David H. Ilson, MD, PhD, Associate Editor
- Grant / research support
-
- Bayer; Bristol-Myers Squibb; Genentech; sanofi-aventis
Henry Mark Kuerer, MD, PhD, FACS, Associate Editor
- Leadership positions in professional societies
-
- American College of Surgeons Oncology Group (Chair, Education Committee); American Society of Breast Surgeons (Research Committee); Society of Surgical Oncology (Program Directors Committee)
Barbara A. Murphy, MD, Associate Editor
- Consultant / Advisory board
-
- Bristol-Myers Squibb; MedImmune
- Speaker's bureau
-
- Amgen; Bristol-Myers Squibb
- Grant / research support
-
- MedImmune
- Editorial boards
-
- Journal of Supportive Oncology
- Leadership positions in professional societies
-
- Eastern Cooperative Oncology Group (Chair for Head and Neck Cancer)
Michael E. Williams, MD, Associate Editor
- Consultant / Advisory board
-
- Celgene
- Speaker's bureau
-
- Educational Concepts Group; Network for Oncology Communication and Research/Xcenda
- Grant / research support
-
- Allos Therapeutics; Celgene; Cephalon; Genentech; Millennium; Novartis
- Editorial boards
-
- Modern Pathology
- Leadership positions in professional societies
-
- European Mantle Cell Lymphoma Network (Member, Scientific Advisory Group); Lymphoma Research Foundation (Chair, Mantle Cell Lymphoma Consortium and Member, Scientific Advisory Board)
Editors who have left the board since January 2007
Lin-Chi Chen, MD, PhD, Associate Editor
- Consultant / Advisory board
-
- Genentech
Manuel Hidalgo, MD, PhD, Associate Editor 2006-2008
- Consultant / Advisory board
-
- Amgen; AstraZeneca
- Grant / research support
-
- AstraZeneca; EISAI; RayBiotech; Wyeth
- Editorial boards
-
- Molecular Cancer Therapeutics
This information reflects Dr. Hidalgo's annual report of disclosable interests at the time he was last affiliated with Journal Watch, in 2008.
Mark A. Socinski, MD, Associate Editor 2006–2007
- Consultant / Advisory board
-
- Genentech; Eli Lilly
- Speaker's bureau
-
- Amgen; Genentech; Eli Lilly; sanofi-aventis
- Grant / research support
-
- Genentech; Eli Lilly; Pfizer; sanofi-aventis
- Editorial boards
-
- Journal of Clinical Oncology
This information reflects Dr. Socinski's annual report of disclosable interests at the time he was last affiliated with Journal Watch, in 2007.
